Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2025 Jun 4;80(5):1080-1087.
doi: 10.1093/cid/ciae633.

Performance of Diagnostic Algorithms in Patients With Invasive Pulmonary Aspergillosis

Affiliations
Multicenter Study

Performance of Diagnostic Algorithms in Patients With Invasive Pulmonary Aspergillosis

Stefan Hatzl et al. Clin Infect Dis. .

Abstract

Background: Invasive pulmonary aspergillosis (IPA), once limited to immunocompromised patients, is now a severe complication in critically ill ICU patients without classic risk factors. Due to the difficulty of obtaining histological evidence, diagnosis relies on poorly tested algorithms in real-world settings.

Methods: We conducted a retrospective multicenter (n = 9) cohort study including 202 patients with IPA. Patients were classified using a multistep process based on the EuropeanOrganization- for-the-Research-and-Treatment-of-Cancer/Mycosis-Study Group (EORTC-MSG), Invasive-Fungal-Diseases-in-Adult-Patients-in-Intensive-Care-Unit (FUNDICU), Aspergillus-ICU (Asp-ICU), and Asp-ICU with biomarkers (Asp-ICU-BM) criteria. We then evaluated the predictive performance of these criteria against the clinical cohort and histologically proven cases.

Results: Among 202 patients, 78 had EORTC-MSG host factors and were classified accordingly, with EORTC-MSG criteria achieving 100% agreement in identifying clinical and histologically proven cases. In 112 ICU patients without EORTC-MSG host factors, overall agreement was 53% for FUNDICU, 4% for Asp-ICU, and 26% for Asp-ICU-BM versus the clinical cohort. Validation against histologically proven cases showed FUNDICU had 44% sensitivity and 75% specificity, Asp-ICU 6% sensitivity and 100% specificity, and Asp-ICU-BM 28% sensitivity and 63% specificity. Adding acute respiratory distress syndrome (ARDS) and post-cardiac surgery to the FUNDICU criteria improved sensitivity to 97% with a specificity of 63%. The remaining 12 patients lacked EORTC-MSG host factors and were not in the ICU, highlighting a novel classification system.

Conclusions: EORTC-MSG and FUNDICU IPA classification systems are useful for the assignment of most patients with IPA. Incorporating postoperative complications after cardiac surgery and ARDS enhanced the diagnostic accuracy of FUNDICU.

Keywords: ICU; IPA; classification; host factors; invasive pulmonary aspergillosis.

PubMed Disclaimer

Figures

Graphical Abstract
Graphical Abstract
Figure 1.
Figure 1.
A–D, The figure summarizes the diagnostic performance of established algorithms for IPA compared with the novel proposed FUNDICU-clinical algorithm. The performance was evaluated against histologically proven cases, with AUROC used as the measure of accuracy. Abbreviations: ASP-ICU, Aspergillus in Intensive Care Units; ASP-ICU-BM, Aspergillus in Intensive Care Units with biomarkers; AUROC, area under the receiver operating characteristic curve; FUNDICU, Invasive Fungal Diseases in Adult Patients in Intensive Care Unit; IPA, invasive pulmonary aspergillosis.

References

    1. Hajjeh RA, Warnock DW. Counterpoint: invasive aspergillosis and the environment—rethinking our approach to prevention. Clin Infect Dis 2001; 33:1549–52. - PubMed
    1. Lass-Flörl C, Roilides E, Löffler J, Wilflingseder D, Romani L. Minireview: host defence in invasive aspergillosis. Mycoses 2013; 56:403–13. - PubMed
    1. Cui L, Morris A, Huang L, et al. The microbiome and the lung. Ann Am Thorac Soc 2014; 11 Suppl 4:S227–32. - PMC - PubMed
    1. Schauwvlieghe AFAD, Rijnders BJA, Philips N, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med 2018; 6:782–92. - PubMed
    1. Koehler P, Bassetti M, Chakrabarti A, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis 2021; 21:e149–62. - PMC - PubMed

Publication types